Seer Bio

IPO

Unbiased, deep, rapid proteomics at scale

Public · Redwood City, United States · Founded 2017 · $95.0M raised

Employees
51–200
Founded
2017
Business Model
B2B
Website
seer.bio
Total Funding
$95.0M
Last Round
$55.0M Series DJul 2020
Rounds
4
Type
Public

About

Seer is a life sciences company commercializing the Proteograph Product Suite, a disruptive platform for large-scale, unbiased proteomics. Its nanoparticle-based technology enables researchers to access the breadth and depth of the proteome from plasma samples, advancing cancer, cardiovascular, and neurodegenerative disease research. Seer is publicly traded on Nasdaq (SEER) and headquartered in Redwood City, California.

Summary

Seer Bio is a Biotech company based in Redwood City, United States, founded in 2017. It has raised $95.0M in total across 4 rounds, most recently a $55.0M Series D round in Jul 2020. Investors include Invus, Maverick Ventures and J.P. Morgan.

Tech & App Stack

11 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

IPODec 2020
$336.2M

Sign up to see all 5 rounds

Series A through IPO — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Seer Bio on Indexed.vc
<a href="https://indexed.vc/companies/seer-bio"><img src="https://indexed.vc/api/badge/company/seer-bio" alt="Seer Bio on Indexed.vc" width="260" height="76" /></a>